Wang, T., Yang, J. Y., Buse, J. B., Pate, V., Tang, H., Barnes, E. L., . . . Stürmer, T. (2019). Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults. Diabetes Care.

Wang, Tiansheng, Jeff Y. Yang, John B. Buse, Virginia Pate, Huilin Tang, Edward L. Barnes, Robert S. Sandler, و Til Stürmer. "Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults." Diabetes Care 2019.

Wang, Tiansheng, et al. "Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults." Diabetes Care 2019.